# FDA Advisory Panel

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/fda-advisory-panel
Canonical HTML page: https://getbiobrief.com/entity/fda-advisory-panel

## Timeline

- **2026-08-05**: FDA Decision Deadline — The agency faces a deadline to approve or reject the vaccine.
- **2026-07**: FDA Advisory Panel Hearing — Marathon hearing votes 6-1 to back compounding of six peptide therapies, including BPC-157, TB-500, and MOTS-c, despite FDA scientists' concerns.
- **2026-06**: Advisory Panel Recommends Approval — An FDA advisory panel votes in favor of approving the vaccine.
- **2026-02**: FDA Issues Refuse-to-File Letter — FDA informs Moderna it will not review the mRNA flu shot application, surprising the company after prior assurances.
- **2026-02**: FDA Accepts Application After Outcry — A little over a week later, the agency reverses its decision after Moderna commits to a confirmatory study.

## Recent coverage (2 stories)

### FDA Panel Greenlights 6 of 7 Peptide Therapies, Signaling Shift in Bioregulatory Framework
2026-08-03 18:47:47 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Despite FDA scientists’ safety concerns, an advisory panel overwhelmingly backed six peptide therapies for compounding, including TB-500 and MOTS-c. The biotech sector watches closely as the FDA prepares for rulemaking, which may redefine the boundary between pharmaceutical development and pharmacy compounding.
Full story: https://getbiobrief.com/story/fdapanel-6-peptide-therapies-bioregulatory-shift

### Moderna's mRNA Flu Shot: FDA Decision by Aug 5 Could End 6-Month Regulatory Ordeal
2026-08-01 15:39:40 · Sentiment: Neutral · Impact: 6/10 · Sources: 6

After a shocking FDA refusal-to-file in February and a subsequent advisory panel endorsement, Moderna's experimental mRNA influenza vaccine faces a final decision on August 5. The outcome holds deep implications for the viability of mRNA technology beyond COVID-19 and the future of Moderna's pipeline diversification.
Full story: https://getbiobrief.com/story/moderna-mrna-flu-shot-fda-decision-aug-5

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.